Precision Diabetes, Inc. (Raleigh, North Carolina) is an emerging leader in enabling precision medicine for diabetes through the use of novel diabetes biomarkers and algorithms. The company’s mission is to revolutionize the diagnostic assessment of diabetes by providing a spectrum of unique diabetes tests, spanning the risk of developing diabetes to developing diabetes complications. Precision Diabetes product portfolio includes several novel diabetes biomarkers and is the exclusive supplier of the GlycoMark test in the U.S., Europe, Australia, the Asia-Pacific Region, the Middle East, and Mexico. Precision Diabetes also has a partnership with Patia Europe to distribute a new type 2 diabetes genetic test, DIABETESpredict, and a genetic test for gestational diabetes, Matergen, in the United States.
Company Details
- Employees
- 3
- Address
- 5540 Centerview Drive, Suite 200, Raleigh,nc 27606,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- IT Consulting.
- HQ
- RALEIGH, NC
Precision Diabetes Inc. Questions
Precision Diabetes Inc.'s website is https://www.precisiondiabetesinc.com/
Precision Diabetes Inc.'s LinkedIn profile is https://www.linkedin.com/company/precision-diabetes-inc
Precision Diabetes Inc. has
3 employees.
View email and phone details for 3
employees at Precision Diabetes Inc..
Precision Diabetes Inc.'s industry is
Biotechnology Research
Precision Diabetes Inc.'s top competitors are
Barrett's Alehouse,
Novo Dx,
Healthtek, Inc.,
Healthbio,
Incelldx,
Glycomark, Inc.,
World Kidney Day,
Us Healthtek,
Alpha Corporation,
Rife International.
Precision Diabetes Inc.'s categories are Biotechnology Research
